PTSD, Post Traumatic Stress Disorder, Posttraumatic Stress Symptoms, Trauma-Related Disorder PTSD, Post Traumatic Stress Disorder, Posttraumatic Stress Symptoms, Trauma-Related Disorder
Conditions
Interventions
Questionnaires will be administered to research participants at multiple time points. In a small subgroup (20-30 participants), an interview will be conducted.
Sponsors
Parnassia
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: To be eligible for inclusion in this study, participants must meet all of the following criteria: • Age between 18 and 65 years • Provide informed consent for the use and sharing of data for research purposes • Proficiency in reading and speaking Dutch • Primary diagnosis of PTSD in accordance with DSM-5 criteria, as determined by a qualified health professional (e.g., psychologist, psychiatrist) For the third phase, participants must meet the following criteria to be eligible: • Age between 18 and 65 years • Provide informed consent for the use and sharing of data for research purposes • Proficiency in reading and speaking Dutch • A confirmed diagnosis of PTSD as assessed with the aid of the Clinician-Administered PTSD Scale (CAPS)
Exclusion criteria
Exclusion criteria: • No PTSD diagnosis • Insufficient command of the Dutch language • Presence of current suicidality (e.g., active suicidal ideation or behavior)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To obtain our primary outcome measures we will employ the PSBS and ASGS for assessing paranormal beliefs. Maladaptive personality traits, specifically Negative Affectivity and Psychoticism, will be evaluated using the PID5-BF-NL and extended PID-5 scales to examine their mediating role between PTSD severity and paranormal beliefs. The Clinician-Administered PTSD Scale (CAPS) will be employed to assess PTSD symptom severity and treatment efficacy. The CAPS will be administered at the start of treatment and at the end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Post-Traumatic Stress Disorder Checklist (PCL-5, a self-re-port instrument comprising 20 items) to assess the severity of PTSD symptoms. • Depressive Attributions Questionnaire (DAQ; Kleim, Gonzalo & Ehlers, 2011) to assess attributional styles linked to depressive symptomatology, in an attempt to gain insight into cognitive patterns that may relate to belief systems or psychological functioning. The effect of paranormal beliefs on PTSD treatment • Life Events Checklist for DSM-5 (LEC-5; Weathers et al., 2013) to evaluate exposure to potentially traumatic events, providing contextual information critical to the understanding of trauma-related symptoms. • Participants will also be asked whether they experience delusions or hallucinations. Here we intend to use the Psychotic Symptom Rating Scales (PSYRATS, Haddock, 1999), a questionnaire that consists of 18 questions divided into a Delusions Scale and an Auditory Hallucinations Scale. • Outcome Questionaire (OQ-45), a self-report questionnaire for adults that assesses psychological and physical distress across 45 items. In addition, we will be recording treatment type (i.e., imagery exposure (IE) versus eye movement desensitization and reprocessing [EMDR]). Finally, qualitative interviews will be conducted to explore the nature and impact of para-normal beliefs, particularly in relation to trauma, providing complementary insights into partici-pants' coping mechanisms.Across all studies, the following demographic characteristics will be collected and may be considered as covariates in exploratory or adjusted analyses: gender, age, educational level, relationship status, employment status, ethnicity, religion and highest education. | — |
Countries
Netherlands
Contacts
Public ContactT.G. Goossens
Parnassia
Outcome results
None listed